Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle


In the October issue of Thrombosis and Haemostasis, Geng et al reported treatment satisfaction with dabigatran versus warfarin among patients with atrial fibrillation (AF) in China. This time-intensive, patient-centred study with high completion rate of standardized telephone interviews provides high-quality data and key insights from the patients' perspectives. 

Read More

Hylek EM. Thromb Haemost 2018;118:2018–9.